How is the ice‑pack test performed for a patient with ptosis suspected of ocular myasthenia gravis, and what defines a positive result and the next steps in management?

Ice Pack Test for Myasthenic Ptosis

How to Perform the Test

Apply an ice pack over the patient's closed eyelids for 2 minutes when evaluating ptosis, or for 5 minutes when evaluating diplopia/strabismus. 1

Step-by-Step Procedure

• Baseline measurement: Measure the margin reflex distance (MRD) before applying ice—this is the distance from the corneal light reflex to the upper eyelid margin 1, 2

• Ice application: Place an ice pack directly on both closed eyelids for exactly 2 minutes for ptosis evaluation 1, 2, 3

  • For diplopia/ophthalmoplegia without significant ptosis, extend application to 5 minutes 1, 4
  • Ensure the ice pack maintains contact with the eyelids throughout the test period 4

• Immediate post-test measurement: Remove the ice pack and immediately measure the MRD again, or perform cover test measurements for diplopia 1, 2

Enhanced Sensitivity Technique for Mild Ptosis

• In Asian patients or those with mild ptosis (common with absent/low double eyelid folds), perform sustained upgaze for 2 minutes immediately before applying the ice pack 5
  • This modification increases sensitivity from 27.8% to 72.2% in patients with mild ptosis 5
  • The conventional test alone has poor sensitivity (43.3%) but combining it with sustained upgaze achieves 73.3% sensitivity while maintaining 96.7% specificity 5

---

Defining a Positive Result

A positive ice pack test is defined as improvement in MRD of ≥2 mm for ptosis, or reduction in ocular deviation by ≥50% (or ≥10 prism diopters for deviations >20 PD) for diplopia. 1, 2, 3, 4

Interpretation Thresholds

• For ptosis: Improvement of at least 2.0 mm in MRD is considered positive 1, 2, 3

  • Improvement of 1.0-1.9 mm is considered "equivocal" and warrants repeat testing 6

• For diplopia/strabismus: Reduction in ocular misalignment by 50% or by 10 prism diopters (for larger deviations >20 PD) 4

  • Partial response is acceptable and still supports myasthenia gravis diagnosis—complete resolution is not required 4

Test Performance Characteristics

• Sensitivity: 76.9-96% depending on whether ptosis or diplopia is being evaluated 2, 3, 4

  • Higher sensitivity (95-96%) for ptosis 2, 3
  • Lower sensitivity (76.9%) for diplopia with 5-minute application 4

• Specificity: 96.7-100% across multiple studies 2, 3, 5, 4

  • The test maintains high specificity even in patients with coexisting thyroid eye disease 4

Repeat Testing Strategy

• If initial test is negative but clinical suspicion remains high, repeat the ice pack test on a separate day 6

  • Repeated testing increases sensitivity by 34.6% compared to a single test 6
  • Agreement between repeated tests is only 61.5% in myasthenia gravis patients, so a second test can capture initially false-negative cases 6

• Among patients with equivocal results (1.0-1.9 mm improvement) on at least one test, 63.6% ultimately have myasthenia gravis 6

  • Patients with repeatedly non-equivocal negative results (consistently <1.0 mm improvement) are unlikely to have myasthenia gravis 6

---

Next Steps in Management After a Positive Ice Pack Test

Immediately order serologic testing for acetylcholine receptor (AChR) antibodies and anti-striated muscle antibodies, and arrange electrodiagnostic studies with repetitive nerve stimulation and/or single-fiber EMG. 1

Immediate Diagnostic Workup

• Serologic testing 1:

  • AChR antibodies (positive in only 40-77% of ocular myasthenia) 1
  • If AChR antibodies are negative, order anti-muscle-specific kinase (MuSK) antibodies—approximately one-third of seronegative cases are MuSK-positive 1
  • Consider anti-lipoprotein-related protein 4 (LRP4) antibodies in the serologic workup 1
  • Note: About 50% of purely ocular myasthenia patients are seronegative for AChR antibodies, so negative results do not exclude the diagnosis 1

• Electrodiagnostic studies 1:

  • Single-fiber EMG has >90% sensitivity for ocular myasthenia and is the gold-standard test 1
  • Repetitive nerve stimulation studies 1
  • These studies are operator-dependent and require specialized equipment and expertise 1

• Imaging studies 1:

  • Chest CT to evaluate for thymoma (30-50% of thymoma patients have myasthenia gravis) 1
  • Consider brain MRI to exclude brainstem lesions that can mimic myasthenia 1

Initial Treatment Approach

• Start pyridostigmine 30 mg orally three times daily, gradually increasing to a maximum of 120 mg orally four times daily as tolerated 1

  • This is first-line therapy for MGFA Class I (ocular symptoms only) 1
  • Approximately 50% of ocular myasthenia patients show minimal response to pyridostigmine alone, which does not rule out the diagnosis 1

• If symptoms persist despite pyridostigmine, escalate to corticosteroids (prednisone 1-1.5 mg/kg orally daily) 1

  • Approximately 66-85% of patients show positive response to corticosteroids 1

Critical Monitoring and Follow-Up

• Assess respiratory function regularly, as 50-80% of patients with initial ocular symptoms will develop generalized myasthenia within a few years (most commonly within the first 2 years) 1

  • Regular pulmonary function testing is crucial to monitor for respiratory compromise 1

• Watch for high-risk features indicating impending myasthenic crisis 1:

  • Dysphagia/bulbar weakness is present in >50% of cases preceding myasthenic crisis 1
  • Shortness of breath with light activity requires immediate pulmonary function assessment 1

• Avoid medications that can exacerbate myasthenia gravis: β-blockers, IV magnesium, fluoroquinolones, aminoglycosides, and macrolides 1

Specialist Referral

• Arrange collaboration between an experienced ophthalmologist and neurologist for ongoing diagnosis and management 1

  • This is particularly important for patients with ocular involvement 1

• Consider evaluation for thymectomy if appropriate 1

  • All patients suspected of having thymomas should have serum anti-AChR antibody levels measured before any surgical procedure 1

---

Key Diagnostic Pitfalls to Avoid

Pupillary Examination is Critical

• Always assess pupillary function as part of the initial examination—pupils are characteristically NOT affected in myasthenia gravis 1
  • Myasthenia affects nicotinic receptors at skeletal muscle neuromuscular junctions, not autonomic nervous system receptors controlling pupillary function 1, 7
  • If pupils are abnormal, immediately prioritize evaluation for third nerve palsy, Horner syndrome, or other neurologic causes over myasthenia gravis 1

False Negatives in Mild Ptosis

• Standard ice pack testing has poor sensitivity (27.8%) in patients with mild ptosis 5
  • Use the sustained upgaze modification (2 minutes of upgaze before ice application) to increase sensitivity to 72.2% 5
  • This is particularly important in Asian patients who commonly have absent or low double eyelid folds 5

Distinguishing from Other Causes

• Thyroid eye disease can be distinguished by proptosis, eyelid retraction, and mechanical restriction on forced duction testing 1

  • Orbital imaging shows tendon-sparing muscle enlargement in thyroid eye disease versus normal imaging in myasthenia 1
  • The ice pack test maintains 98.3% specificity even in patients with coexisting thyroid ophthalmopathy 4

• Third nerve palsy typically involves pupillary abnormalities and requires immediate neuroimaging and vascular workup given risk of aneurysm or ischemia 1

• Patients with oculomotor nerve paresis and Horner syndrome are invariably nonresponsive to the ice pack test 4

Physiologic Basis of the Test

• Cooling slows acetylcholine breakdown at the neuromuscular junction, allowing limited acetylcholine to remain in the synaptic cleft longer 7
  • This partially compensates for the reduced acetylcholine receptor availability caused by autoantibodies in myasthenia gravis 7
  • The test has high specificity because this mechanism is unique to neuromuscular junction disorders 1, 7